These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11291887)

  • 1. How can we prevent viral reactivation in liver transplantation from donors with latent hepatitis B virus infection?
    Marusawa H; Chiba T
    J Gastroenterol; 2001 Mar; 36(3):212-3. PubMed ID: 11291887
    [No Abstract]   [Full Text] [Related]  

  • 2. Viral hepatitis in liver transplant recipients.
    Bodenheimer HC; Schluger LK; Sheiner P
    Clin Transplant; 1995 Jun; 9(3 Pt 2):211-4. PubMed ID: 7670165
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunoprophylaxis against and prevention of recurrent viral hepatitis after liver transplantation.
    Laryea MA; Watt KD
    Liver Transpl; 2012 May; 18(5):514-23. PubMed ID: 22315212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Liver transplantation].
    Fehérvári I
    Magy Seb; 2009 Aug; 62(4):250-2. PubMed ID: 19679535
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatitis after transplantation.
    Ye MQ; Thung SN
    Liver Transpl Surg; 1998 Sep; 4(5 Suppl 1):S68-72. PubMed ID: 9742496
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment for recurrent viral hepatitis after liver transplantation.
    Brumage LK; Wright TL
    J Hepatol; 1997 Feb; 26(2):440-5. PubMed ID: 9059971
    [No Abstract]   [Full Text] [Related]  

  • 7. Meeting report of the 16th Annual International Congress of the International Liver Transplantation Society.
    Levitsky J; Guckelberger O
    Liver Transpl; 2011 Jan; 17(1):10-4. PubMed ID: 21254339
    [No Abstract]   [Full Text] [Related]  

  • 8. Liver transplantation for viral hepatitis in 2015.
    Ferrarese A; Zanetto A; Gambato M; Bortoluzzi I; Nadal E; Germani G; Senzolo M; Burra P; Russo FP
    World J Gastroenterol; 2016 Jan; 22(4):1570-81. PubMed ID: 26819523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B virus (HBV) re-infection following liver transplantation: theory and practice.
    Fung JJ; Eghtesad B; Todo S; Rakela J; Magnone M; Starzl TE
    Clin Transplant; 1995 Jun; 9(3 Pt 2):262-8. PubMed ID: 7670174
    [No Abstract]   [Full Text] [Related]  

  • 10. De novo and apparent de novo hepatitis B virus infection after liver transplantation.
    Roche B; Samuel D; Gigou M; Feray C; Virot V; Schmets L; David MF; Arulnaden JL; Bismuth A; Reynes M; Bismuth H
    J Hepatol; 1997 Mar; 26(3):517-26. PubMed ID: 9075658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of hepatitis B virus core antibody-positive grafts in liver transplantation: A single-center experience in China.
    Lei M; Yan LN; Yang JY; Wen TF; Li B; Wang WT; Wu H; Xu MQ; Chen ZY; Wei YG
    World J Gastroenterol; 2018 Dec; 24(48):5525-5536. PubMed ID: 30622380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B and C: an overview.
    Bodenheimer HC
    Liver Transpl Surg; 1998 Sep; 4(5 Suppl 1):S65-7. PubMed ID: 9742495
    [No Abstract]   [Full Text] [Related]  

  • 13. Management of viral hepatitis: clinical and public health perspectives--a consensus statement. CASL Hepatitis Consensus Group. Canadian Association for Study of the Liver.
    Sherman M
    Can J Gastroenterol; 1997; 11(5):407-16. PubMed ID: 9286474
    [No Abstract]   [Full Text] [Related]  

  • 14. Beneficial effect of lamivudine pre- and post-liver transplantation for hepatitis B infection.
    Ben-Ari Z; Shmueli D; Mor E; Shaharabani E; Bar-Nathan N; Shapira Z; Tur-Kaspa R
    Transplant Proc; 1997 Sep; 29(6):2687-8. PubMed ID: 9290790
    [No Abstract]   [Full Text] [Related]  

  • 15. How to improve long-term outcome after liver transplantation?
    Durand F
    Liver Int; 2018 Feb; 38 Suppl 1():134-138. PubMed ID: 29427483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis viruses and liver transplantation.
    Samuel D; Feray C; Bismuth H
    J Gastroenterol Hepatol; 1997 Oct; 12(9-10):S335-41. PubMed ID: 9407355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of backward bifurcation in a model of hepatitis B and C viruses.
    Qesmi R; Wu J; Wu J; Heffernan JM
    Math Biosci; 2010 Apr; 224(2):118-25. PubMed ID: 20085774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De novo hepatitis B virus infection after pediatric liver transplantations with hepatitis B core antibody-positive donors: a single-center 20-yr experience.
    Lee YJ; Oh SH; Kim KM; Song SM; Namgoong JM; Kim DY; Lee SG
    Pediatr Transplant; 2015 May; 19(3):267-72. PubMed ID: 25648049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of occult hepatitis B virus infection in liver transplant donors through hepatitis B virus blood markers.
    Tandoi F; Caviglia GP; Pittaluga F; Abate ML; Smedile A; Romagnoli R; Salizzoni M
    Dig Liver Dis; 2014 Nov; 46(11):1020-4. PubMed ID: 25201211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term lamivudine monotherapy prevents development of hepatitis B virus infection in hepatitis B surface-antigen negative liver transplant recipients from hepatitis B core-antibody-positive donors.
    Prakoso E; Strasser SI; Koorey DJ; Verran D; McCaughan GW
    Clin Transplant; 2006; 20(3):369-73. PubMed ID: 16824156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.